v3.22.2.2
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended 12 Months Ended
Oct. 29, 2022
Jul. 30, 2022
Apr. 30, 2022
Jan. 29, 2022
Oct. 30, 2021
Jul. 31, 2021
Oct. 29, 2022
Oct. 30, 2021
Apr. 30, 2022
Statement of Cash Flows [Abstract]                  
Net income (loss) $ 53,649 $ 24,260 $ 63,399 $ 56,575 $ 47,938 $ 33,802 $ 77,909 $ 81,740  
Adjustments to reconcile net income to net cash used in operating activities:                  
Depreciation             22,412 21,825  
Amortization             18,678 19,155  
Gains on investments 0       0   0 (87,827)  
Non-cash employee compensation             8,393 13,497  
Non-cash losses (gains) and other, net             5,085 3,974  
Change in assets and liabilities:                  
Receivables             (508,811) (583,939)  
Inventory             (100,596) (90,728)  
Accounts payable             41,557 165,250  
Accrued liabilities             (47,519) (56,029)  
Other changes from operating activities, net             (37,269) (25,932)  
Net cash used in operating activities             (520,161) (539,014)  
Investing activities:                  
Additions to property and equipment             (26,779) (15,503)  
Collection of DPP receivable             489,639 585,647  
Payments related to acquisitions, net of cash acquired             0 (19,793)  
Payments related to investments             (15,000) 0  
Sale of investments             0 57,245  
Net cash provided by investing activities             447,860 607,596  
Financing activities:                  
Dividends paid             (50,732) (50,407)  
Repurchases of common stock             (15,000) 0  
Draw (payment) on revolving credit             145,000 (10,000)  
Other financing activities             (1,766) 1,959  
Net cash provided by (used in) financing activities             77,502 (58,448)  
Effect of exchange rate changes on cash             (6,935) 774  
Net change in cash and cash equivalents             (1,734) 10,908  
Cash and cash equivalents at beginning of period   $ 142,014   $ 154,152   $ 143,244 142,014 143,244 $ 143,244
Cash and cash equivalents at end of period $ 140,280   $ 142,014   $ 154,152   140,280 154,152 $ 142,014
Supplemental disclosure of non-cash investing activity:                  
Noncash investments acquired             $ 479,797 $ 549,693